[source: Centers for Disease Control and Prevention www.cdc.gov ]

According to the United States Centers for Disease Control and Prevention (CDC), the following requirements are compulsory for all passengers two years of age or older boarding a flight from a foreign country to the United States.

Testing Requirements:

• If you plan to travel internationally, you will need to get a COVID-19 viral test (regardless of vaccination status) before you travel by air into the United States. You must show your negative result to the airline before you board your flight.
  • Fully vaccinated: The viral test must be conducted on a sample taken no more than 3 days before the flight’s departure from a foreign country if you show proof of being fully vaccinated against COVID-19.
  • Not fully vaccinated: The viral test must be conducted on a sample taken no more than 1 day before the flight’s departure from a foreign country if you do not show proof of being fully vaccinated against COVID-19.
• If you recently recovered from COVID-19, you may instead travel with documentation of recovery from COVID-19 (i.e., your positive COVID-19 viral test result on a sample taken no more than 90 days before the flight’s departure from a foreign country and a letter from a licensed healthcare provider or a public health official stating that you were cleared to travel).

Vaccination Requirements:

• If you are a non-U.S. citizen who is a nonimmigrant (not a U.S. citizen, U.S. national, lawful permanent resident, or traveling to the United States on an immigrant visa), you will need to show proof of being fully vaccinated against COVID-19 before you travel by air to the United States from a foreign country.
• Some categories of noncitizen, nonimmigrants are exempted from this requirement. If you meet the criteria for one of these categories, you will need to fulfil additional requirements to travel by air to the United States.

You are considered fully vaccinated:

• 2 weeks (14 days) after your dose of an accepted single-dose vaccine
• 2 weeks (14 days) after your second dose of an accepted 2-dose series
• 2 weeks (14 days) after you received the full series of an accepted COVID-19 vaccine (not placebo) in a clinical trial
• 2 weeks (14 days) after you received the full series of a Novavax (or Covovax) COVID-19 vaccine (not placebo) in a phase 3 clinical trial
• 2 weeks (14 days) after you received 2 doses of any “mix-and-match” combination of accepted COVID-19 vaccines administered at least 17 days apart*

If you don’t meet these requirements, you are NOT considered fully vaccinated.

For more information, please refer to the CDC Guidelines available at www.cdc.gov